Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
137.00
Ask:
140.00
Spread: 3.00 (2.19%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management & AGM Stat

13 May 2008 06:00

RNS Number : 2510U
Xaar PLC
13 May 2008
 



FOR IMMEDIATE RELEASE

13 May 2008

Xaar plc

INTERIM MANAGEMENT AND AGM STATEMENT

Xaar plc ("Xaar"), the inkjet printing technology group headquartered in Cambridge, is holding its Annual General Meeting today and is providing an Interim Management Statement covering trading from 1 January 2008 to date.

Trading to date in 2008 has followed its historic pattern. The first quarter of the calendar year is Xaar's quietest trading period due to the Chinese New Year holiday period and, therefore, is not indicative of any trend for the year as a whole. Since the end of the first quarter momentum is now building as the second quarter progresses. China is by far the largest market for Platform 1 products which currently comprise the bulk of sales.

Progress in OEM (Original Equipment Manufacturer) product launches incorporating Xaar's new Platform 2 and Platform 3 product ranges is encouraging with 12 committed product launches made public to date. A number of other announcements are expected to be made during the forthcoming Drupa 2008 international trade show to be held in Dusseldorf from 29 May to 11 June 2008.  Volumes of these new products are expected to grow through the balance of 2008 and begin to contribute significantly over the next few years.

The next stage of growth for the company is directly related to the rate of adoption of Xaar's new Platform 2 and, more significantly, Platform 3 products and their successful implementation remain the company's primary goal. Sales of these new products are expected to be incremental to the sales of the existing Platform 1 products which continue to provide a solid base for the company.

Gross margins across the product range are stable, operating costs continue to be controlled successfully and trading for the company as a whole for 2008 is in line with Directors' expectations.

Ends

CONTACTS

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director 

Bankside Consultants:

Steve Liebmann

020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFKBKQABKDQPD
Date   Source Headline
1st Jul 20221:10 pmRNSTotal Voting Rights
21st Jun 20225:20 pmRNSDirector Declaration - Additional Directorship
1st Jun 202210:22 amRNSTotal Voting Rights
25th May 20221:57 pmRNSResult of AGM
3rd May 20225:20 pmRNSTotal Voting Rights
7th Apr 20226:31 pmRNSPDMR Shareholding
7th Apr 20222:50 pmRNSGrant of Options and Deferred Bonus Share Awards
1st Apr 202210:48 amRNSTotal Voting Rights
29th Mar 20227:00 amRNS2021 Full Year Results
28th Mar 202210:44 amRNSHolding(s) in Company
21st Mar 202212:37 pmRNSNotice of 2021 Preliminary Results
3rd Mar 20227:00 amRNSAcquisition of Megnajet
1st Mar 20225:29 pmRNSTotal Voting Rights
1st Feb 20225:00 pmRNSTotal Voting Rights
18th Jan 20224:35 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Update
4th Jan 20222:39 pmRNSBlock listing Interim Review
4th Jan 20222:37 pmRNSTotal Voting Rights
10th Dec 20214:23 pmRNSGrant of Awards - Replacement
6th Dec 202112:25 pmRNSHolding(s) in Company
1st Dec 20215:00 pmRNSTotal Voting Rights
5th Nov 202110:30 amRNSGrant of Sharesave Options
1st Nov 20214:11 pmRNSCompletion of Divestment of Xaar 3D
1st Nov 20211:56 pmRNSTotal Voting Rights
29th Oct 20214:41 pmRNSSecond Price Monitoring Extn
29th Oct 20214:36 pmRNSPrice Monitoring Extension
25th Oct 202110:38 amRNSResult of General Meeting
15th Oct 202111:50 amRNSGrant of Options and Deferred Bonus Share Awards
14th Oct 20218:44 amRNSBlock Listing Application
13th Oct 20212:52 pmRNSHolding(s) in Company
6th Oct 20212:43 pmRNSPublication of Circular and Notice of GM
6th Oct 20217:00 amRNSProposed divestment of Xaar 3D
1st Oct 202111:59 amRNSTotal Voting Rights
14th Sep 20217:00 amRNS2021 Interim Results
3rd Sep 202112:59 pmRNSNotice of 2021 Interim Results
2nd Sep 20213:40 pmRNSTotal Voting Rights
2nd Aug 20215:02 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSTrading Update
12th Jul 20217:00 amRNSAcquisition of FFEI
1st Jul 20213:20 pmRNSBlock listing Interim Review
1st Jul 202110:51 amRNSTotal Voting Rights
22nd Jun 20215:37 pmRNSHolding(s) in Company
22nd Jun 202111:44 amRNSHolding(s) in Company
16th Jun 20211:17 pmRNSResult of AGM
1st Jun 202110:10 amRNSTotal Voting Rights
17th May 20219:27 amRNSHolding(s) in Company
12th May 202110:15 amRNSHolding(s) in Company
4th May 20213:01 pmRNSTotal Voting Rights
30th Apr 20216:23 pmRNSAnnual Financial Report
27th Apr 20217:00 amRNS2020 FULL YEAR RESULTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.